The Indianapolis-based health care company’s stock, which trades on the NYSE Amex Equities exchange, has closed at an average price of less than 20 cents over a consecutive 30-day trading period, triggering the warning.
Dan Ferber is a freelance magazine writer in Indianapolis who writes about science, health and the environment for such publications as Science, Popular Science, New Scientist, Audubon, and Women's Health. He co-authored a new book with Harvard Medical School's Dr. Paul Epstein titled "Changing Planet, Changing Health: How the Climate Crisis Threatens Our Health and What We Can Do about It." It was published this month.
The total annual cost for one researcher at Lilly might run $300,000 to $350,000 a year. The figure at Crown Bioscience is one-third of that, said a company executive.
An Indianapolis insurance brokerage disciplined for unauthorized legal practice might now face millions of dollars in claims from more than 4,000 former clients because of a class-action suit filed in Marion Superior Court.
TechPoint-led initiative is meant to help bring inventions to market by giving them a trial in real-world setting.
A Michigan insurance company is seeking to avoid paying for any claims made by Mavris Arts & Event Center in Indianapolis involving a high-profile fatal wedding-shuttle accident last summer.
All publicly traded companies have to allow advisory votes about top executives compensation every two or three under the Dodd-Frank financial reform passed by Congress last year.
Being an accountable care organization will be the major leagues of health care after the federal Medicare program set a high bar for the new kind of doctor-hospital organization.
Physicians are regarded as smart, successful and helpful when you’re sick—but not usually as a big driver of the economy. Now, however, physician trade groups are arguing that docs are good for business too.
The study included Eli Lilly and Co. drug Cymbalta, which racked up sales of $3.5 billion last year for the Indianapolis-based drugmaker.
Northern Indiana's Manchester College plans to begin work this summer on the college's new $18 million pharmacy school.
The widespread Internet posting of a letter by a retired Purdue University researcher who says he has linked genetically modified corn and soybeans to crop diseases and to abortions and infertility in livestock has raised concern among scientists that the public will believe his unsupported claim is true.
Eli Lilly and Co. is starting a service program that sends employees around the world to help developing communities and learn about other cultures, as the drugmaker looks to international markets.
A new report says Hamilton and Boone counties are among the healthiest in Indiana, while Marion ranks among the worst.
The Mishawaka-based Franciscan Alliance plans to spend $8.4 million to open an administrative center in Greenwood, creating 84 jobs in the next four years.
Tom Swoik, executive director of Illinois Casino Gaming Association, said gambling revenue has dropped 32 percent since the state’s smoking ban was approved. He said the ban has cost state government about $800 million in taxes.
Susan Rider is an employee-benefits account manager at Indianapolis-based Gregory & Appel Insurance. On July 1, she will become president of the Indiana State Association of Health Underwriters. She spoke about the first-year impact of the 2010 health reform law and further changes to come.
The Warsaw-based maker of orthopedic implants has filed suit to stop a Detroit-area law firm from making allegedly false claims and using its trademarks on websites designed to attract plaintiffs to sue Zimmer over one of its knee-replacement implants called NexGen.
Health reform will make health insurance a less-profitable business, but WellPoint Inc. got a vote of confidence from bond analysts because health-reform rules have turned out milder than expected and WellPoint’s financial performance has been particularly strong as the economy recovers.
Premiums for private health insurers in China are expected to rise to $90 billion by 2020 from $9 billion now, and WellPoint Inc. is angling for a big piece of that pie.
